Want to see CORZ full AI Analyst Report?
Core Scientific Inc (CORZ) Ratios
Core Scientific Inc Ratios
CORZ's free cash flow for Q2 2026 was $-583.95M. For the 2026 fiscal year, CORZ's free cash flow was decreased by $-565.02M and operating cash flow was $-18.93M. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 1.15 | 6.72 | 0.20 | 0.46 | 2.36 |
| Quick Ratio | 1.15 | 6.72 | 0.20 | 0.46 | 2.36 |
| Cash Ratio | 0.40 | 6.21 | 0.10 | 0.09 | 0.37 |
| Solvency Ratio | -0.06 | -0.49 | -0.11 | -1.58 | 0.07 |
| Operating Cash Flow Ratio | 0.36 | 0.32 | 0.13 | 1.10 | -0.18 |
| Short-Term Operating Cash Flow Coverage | 0.00 | 2.63 | 0.52 | 5.66 | -0.75 |
| Net Current Asset Value | $ -2.41B | $ -1.52B | $ -1.21B | $ -1.13B | $ -341.09M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.45 | 0.75 | 1.22 | 0.05 | 0.34 |
| Debt-to-Equity Ratio | -1.10 | -1.46 | -1.45 | -0.09 | 0.61 |
| Debt-to-Capital Ratio | 10.87 | 3.16 | 3.22 | -0.10 | 0.38 |
| Long-Term Debt-to-Capital Ratio | 10.87 | 4.23 | 7.85 | 0.00 | 0.33 |
| Financial Leverage Ratio | -2.44 | -1.95 | -1.19 | -1.97 | 1.82 |
| Debt Service Coverage Ratio | 0.00 | -21.70 | -0.30 | -13.70 | 1.04 |
| Interest Coverage Ratio | 0.00 | -0.52 | 0.10 | -21.79 | 3.76 |
| Debt to Market Cap | 0.23 | 0.30 | 0.62 | 0.03 | 1.02 |
| Interest Debt Per Share | 3.33 | 4.83 | 2.51 | 0.40 | 4.16 |
| Net Debt to EBITDA | -3.60 | -0.31 | -12.91 | -0.01 | 4.98 |
| Profitability Margins | |||||
| Gross Profit Margin | 11.88% | 23.71% | 24.57% | 1.31% | 43.87% |
| EBIT Margin | -90.29% | -250.08% | -31.76% | -322.75% | 19.73% |
| EBITDA Margin | -65.15% | -226.56% | -12.56% | -287.44% | 25.86% |
| Operating Profit Margin | -70.39% | -3.76% | 1.78% | -329.46% | 30.61% |
| Pretax Profit Margin | -90.29% | -257.34% | -48.93% | -337.87% | 11.58% |
| Net Profit Margin | -90.47% | -257.50% | -49.06% | -335.20% | 8.69% |
| Continuous Operations Profit Margin | -90.47% | -257.50% | -49.06% | -335.20% | 8.69% |
| Net Income Per EBT | 100.20% | 100.07% | 100.28% | 99.21% | 75.01% |
| EBT Per EBIT | 128.27% | 6845.94% | -2743.04% | 102.55% | 37.85% |
| Return on Assets (ROA) | -12.29% | -82.25% | -34.61% | -265.74% | 1.94% |
| Return on Equity (ROE) | 29.98% | 160.33% | 41.29% | 524.33% | 3.53% |
| Return on Capital Employed (ROCE) | -14.34% | -1.31% | 4.01% | -339.76% | 7.87% |
| Return on Invested Capital (ROIC) | -14.34% | -1.29% | 2.44% | -318.11% | 5.62% |
| Return on Tangible Assets | -12.29% | -82.25% | -34.72% | -266.30% | 3.44% |
| Earnings Yield | -6.23% | -36.58% | -18.86% | -183.16% | 6.64% |
| Efficiency Ratios | |||||
| Receivables Turnover | 0.95 | 498.22 | 70.18 | 180.78 | 323.71 |
| Payables Turnover | 2.23 | 20.22 | 2.45 | 11.78 | 26.31 |
| Inventory Turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Fixed Asset Turnover | 0.23 | 0.76 | 0.85 | 0.90 | 0.91 |
| Asset Turnover | 0.14 | 0.32 | 0.71 | 0.79 | 0.22 |
| Working Capital Turnover Ratio | 0.72 | 2.70 | -2.04 | 3.83 | 2.49 |
| Cash Conversion Cycle | 222.02 | -17.32 | -143.86 | -28.96 | -12.75 |
| Days of Sales Outstanding | 385.75 | 0.73 | 5.20 | 2.02 | 1.13 |
| Days of Inventory Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Days of Payables Outstanding | 163.73 | 18.05 | 149.06 | 30.98 | 13.87 |
| Operating Cycle | 385.75 | 0.73 | 5.20 | 2.02 | 1.13 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | 0.87 | 0.17 | 0.17 | 0.60 | -0.27 |
| Free Cash Flow Per Share | -1.42 | -0.20 | 0.13 | -1.16 | -0.56 |
| Dividend Paid and CapEx Coverage Ratio | 0.38 | 0.45 | 4.03 | 0.34 | -0.96 |
| Capital Expenditure Coverage Ratio | 0.38 | 0.45 | 4.03 | 0.34 | -0.96 |
| Operating Cash Flow Coverage Ratio | 0.26 | 0.04 | 0.08 | 5.44 | -0.07 |
| Operating Cash Flow to Sales Ratio | 0.87 | 0.08 | 0.13 | 0.32 | -0.10 |
| Free Cash Flow Yield | -9.73% | -1.45% | 3.75% | -33.83% | -16.27% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | -16.55 | -2.73 | -5.30 | -0.55 | 15.07 |
| Price-to-Sales (P/S) Ratio | 14.52 | 7.04 | 2.60 | 1.83 | 1.31 |
| Price-to-Book (P/B) Ratio | -4.81 | -4.38 | -2.19 | -2.86 | 0.53 |
| Price-to-Free Cash Flow (P/FCF) Ratio | -10.27 | -69.04 | 26.69 | -2.96 | -6.15 |
| Price-to-Operating Cash Flow Ratio | 16.64 | 83.79 | 20.07 | 5.71 | -12.57 |
| Price-to-Earnings Growth (PEG) Ratio | 0.20 | -0.00 | 0.06 | 0.00 | -0.00 |
| Enterprise Value Multiple | -25.88 | -3.42 | -33.62 | -0.65 | 10.04 |
| Enterprise Value | 5.38B | 3.96B | 2.12B | 1.19B | 1.41B |
| EV to EBITDA | -25.88 | -3.42 | -33.62 | -0.65 | 10.04 |
| EV to Sales | 16.86 | 7.75 | 4.22 | 1.86 | 2.60 |
| EV to Free Cash Flow | -11.94 | -76.02 | 43.34 | -3.01 | -12.19 |
| EV to Operating Cash Flow | 19.34 | 92.27 | 32.59 | 5.82 | -24.92 |
| Tangible Book Value Per Share | -3.03 | -3.21 | -1.58 | -1.21 | 1.34 |
| Shareholders’ Equity Per Share | -3.03 | -3.21 | -1.57 | -1.20 | 6.47 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | -0.00 | -0.00 | -0.00 | 0.01 | 0.25 |
| Revenue Per Share | 1.00 | 2.00 | 1.32 | 1.88 | 2.63 |
| Net Income Per Share | -0.91 | -5.14 | -0.65 | -6.30 | 0.23 |
| Tax Burden | 1.00 | 1.00 | 1.00 | 0.99 | 0.75 |
| Interest Burden | 1.00 | 1.03 | 1.54 | 1.05 | 0.59 |
| Research & Development to Revenue | 0.00 | 0.02 | 0.01 | 0.04 | 0.01 |
| SG&A to Revenue | 0.57 | 0.24 | 0.19 | 0.33 | 0.00 |
| Stock-Based Compensation to Revenue | 0.31 | 0.10 | 0.12 | 0.29 | 0.07 |
| Income Quality | -0.96 | -0.03 | -0.26 | -0.10 | -1.20 |
Currency in USD
